Kai‐Hu Shi

1.6k total citations
40 papers, 1.3k citations indexed

About

Kai‐Hu Shi is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kai‐Hu Shi has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Surgery and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kai‐Hu Shi's work include Cardiac Fibrosis and Remodeling (9 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer-related gene regulation (7 papers). Kai‐Hu Shi is often cited by papers focused on Cardiac Fibrosis and Remodeling (9 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer-related gene regulation (7 papers). Kai‐Hu Shi collaborates with scholars based in China and Norway. Kai‐Hu Shi's co-authors include Hui Tao, Jingjing Yang, Zi-Yu Deng, Jun Li, Peng Shi, Wei Hu, Xiao Zhou, Liping Liu, Cheng Huang and Xuansheng Ding and has published in prestigious journals such as PLoS ONE, Scientific Reports and Experimental Cell Research.

In The Last Decade

Kai‐Hu Shi

39 papers receiving 1.3k citations

Peers

Kai‐Hu Shi

CCM

SURGE

EPIDE

Temo Barwari United Kingdom

Shoukang Zhu United States

Marish I.F.J. Oerlemans Netherlands

Chuanwu Cao China

Lucian Lozonschi United States

Teiji Oda Japan

Shu-Hong Li China

Yasushi Mochizuki Japan

Shijie Zhou China

Lan Zhang China

Temo Barwari United Kingdom

Kai‐Hu Shi

737 ×0.9

700 ×1.5

183 ×0.5

CCM

137 ×0.9

SURGE

67 ×0.4

EPIDE

Citations per year, relative to Kai‐Hu Shi Kai‐Hu Shi (= 1×) peers Temo Barwari

Countries citing papers authored by Kai‐Hu Shi

Since Specialization

Citations

This map shows the geographic impact of Kai‐Hu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Hu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Hu Shi more than expected).

Fields of papers citing papers by Kai‐Hu Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Hu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Hu Shi. The network helps show where Kai‐Hu Shi may publish in the future.

Co-authorship network of co-authors of Kai‐Hu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Hu Shi. A scholar is included among the top collaborators of Kai‐Hu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Hu Shi. Kai‐Hu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xin, et al.. (2024). DNMT1 methylation of LncRNA-ANRIL causes myocardial fibrosis pyroptosis byinterfering with the NLRP3/Caspase-1 pathway. Cellular and Molecular Biology. 70(3). 197–203. 1 indexed citations

Zhou, Yang, et al.. (2023). IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis. European Journal of Pharmacology. 942. 175494–175494. 25 indexed citations

Zhou, Yang, et al.. (2022). Epigenetic control of LncRNA NEAT1 enables cardiac fibroblast pyroptosis and cardiac fibrosis. European Journal of Pharmacology. 938. 175398–175398. 10 indexed citations

Tao, Hui, Zhengyu Song, Xuansheng Ding, et al.. (2018). LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives. Endocrine. 62(2). 281–291. 12 indexed citations

Tao, Hui, Chen Dai, Peng Shi, et al.. (2017). LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology. 386. 11–18. 119 indexed citations

Tao, Hui, Jingjing Yang, Kai‐Hu Shi, & Jun Li. (2016). Epigenetic factors MeCP2 and HDAC6 control α-tubulin acetylation in cardiac fibroblast proliferation and fibrosis. Inflammation Research. 65(5). 415–426. 37 indexed citations

Tao, Hui, Wei Cao, Jingjing Yang, et al.. (2016). Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis. Cardiovascular Pathology. 25(5). 381–389. 71 indexed citations

Tao, Hui, Jingjing Yang, Wei Hu, et al.. (2016). Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead. Pflügers Archiv - European Journal of Physiology. 468(6). 1103–1111. 22 indexed citations

Tao, Hui, Zewen Chen, Jingjing Yang, & Kai‐Hu Shi. (2016). MicroRNA-29a suppresses cardiac fibroblasts proliferation via targeting VEGF-A/MAPK signal pathway. International Journal of Biological Macromolecules. 88. 414–423. 34 indexed citations

10.

Tao, Hui, Jingjing Yang, Kai‐Hu Shi, & Jun Li. (2015). Wnt signaling pathway in cardiac fibrosis: New insights and directions. Metabolism. 65(2). 30–40. 114 indexed citations

11.

Tao, Hui, Jingjing Yang, & Kai‐Hu Shi. (2015). Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis. Expert Opinion on Therapeutic Targets. 19(5). 707–716. 25 indexed citations

12.

Tao, Hui, Kai‐Hu Shi, Jingjing Yang, & Jun Li. (2015). Epigenetic mechanisms in atrial fibrillation: New insights and future directions. Trends in Cardiovascular Medicine. 26(4). 306–318. 29 indexed citations

13.

Zhao, Xudong, et al.. (2014). Changes of pulmonary function and quality of life in mid-term after lung volume reduction surgery. 30(1). 27–29. 1 indexed citations

14.

Yang, Jingjing, Hui Tao, Wei Hu, et al.. (2014). MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cellular Signalling. 26(11). 2381–2389. 81 indexed citations

15.

Tao, Hui, et al.. (2014). DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2. Toxicology. 323. 42–50. 88 indexed citations

16.

Tao, Hui, Jingjing Yang, Kai‐Hu Shi, et al.. (2014). The significance of YKL-40 protein in liver fibrosis. Inflammation Research. 63(4). 249–254. 34 indexed citations

17.

Yang, Jingjing, Hui Tao, Cheng Huang, et al.. (2013). DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis. Cellular Signalling. 25(5). 1202–1211. 56 indexed citations

18.

Tao, Hui, Kai‐Hu Shi, Jingjing Yang, et al.. (2013). Epigenetic regulation of cardiac fibrosis. Cellular Signalling. 25(9). 1932–1938. 38 indexed citations

19.

Shi, Kai‐Hu, et al.. (2013). Role of microRNAs in atrial fibrillation: New insights and perspectives. Cellular Signalling. 25(11). 2079–2084. 24 indexed citations

20.

Zhang, Mingjun, et al.. (2011). Detection of methylation of the RAR-β gene in patients with non-small cell lung cancer. Oncology Letters. 3(3). 654–658. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact